Pfizer Inc

PFE

Company Profile

  • Business description

    Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

  • Contact

    66 Hudson Boulevard East
    New YorkNY10001-2192
    USA

    T: +1 212 733-2323

    E: [email protected]

    https://www.pfizer.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    81,000

Stocks News & Analysis

stocks

10 cheap wide-moat US stocks for 2025

Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.
stocks

4 defensive, undervalued Moat stocks with limited tariff exposure

In a treacherous time for stocks, long-term investors can look to names with strong competitive advantages.
stocks

10 of the cheapest global companies with wide moats

These undervalued stocks of high-quality companies could be attractive investments today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,772.001.00-0.01%
CAC 407,662.593.32-0.04%
DAX 4023,673.29236.32-0.99%
Dow JONES (US)44,512.14417.370.95%
FTSE 1008,785.3324.370.28%
HKSE24,072.28211.87-0.87%
NASDAQ20,212.22157.51-0.77%
Nikkei 22539,986.33501.06-1.24%
NZX 50 Index12,734.53131.711.05%
S&P 5006,199.115.84-0.09%
S&P/ASX 2008,541.101.20-0.01%
SSE Composite Index3,444.4320.200.59%

Market Movers